Case type Defective Medical Devices

Breast Implant Illness & BIA-ALCL

A laboratory workbench with a microscope.

Diagnosed with BIA-ALCL, or sick after breast implants? Tell us your story.

CBW Law reviews claims from people diagnosed with breast implant-associated lymphoma and from people with documented complications after implants. Tell Us Your Story. Contacting us does not create an attorney-client relationship.

Tell Us Your Story Call (800) 476-2416

Breast implant illness and BIA-ALCL are often mentioned together, but they are different. BIA-ALCL is a lymphoma that can form near an implant, more often with textured implants, and it is diagnosed with lab testing. Breast implant illness describes symptoms throughout the body whose cause is still unclear. A breast implant lawyer looks at the full implant history and what doctors have found.

Two different concerns

People with breast implants sometimes hear two terms used together, but they mean very different things:

  • Breast implant illness (BII): a name patients and some doctors use for a range of symptoms throughout the body that people report after getting implants.
  • BIA-ALCL: a specific cancer of the immune system that can develop near an implant. It is diagnosed by testing fluid or tissue.

A review treats these separately. Someone with a confirmed BIA-ALCL diagnosis, someone being tested for it, and someone with systemic symptoms but no lymphoma are in different situations.

What BIA-ALCL is

Breast implant-associated anaplastic large cell lymphoma is not breast cancer. It is a type of non-Hodgkin lymphoma, a cancer of the immune system. In most cases it is found in the scar tissue and fluid near the implant, but it can spread through the body. The FDA describes an individual's risk as low but notes the cancer is serious and can lead to death, especially if it isn't treated promptly. Most patients are treated successfully with surgery to remove the implant and the surrounding scar tissue; some also need chemotherapy or radiation1.

Symptoms

The main symptoms are persistent swelling, a mass or pain near the implant. They often appear years after the implant was placed. A doctor often finds fluid collected around the implant, called a seroma1.

Textured implants

The FDA has determined that the risk of BIA-ALCL is higher with textured-surface implants than with smooth ones. It also says certain textured tissue expanders, temporary devices used before reconstruction, should not be used1. Because of that, a review asks about every implant and expander a person has had, not only the current one.

The 2019 Allergan BIOCELL recall

On July 24, 2019, at the FDA's request, Allergan began a worldwide recall of its BIOCELL textured breast implants and Natrelle 133 tissue expanders. The FDA said its analysis showed the risk of BIA-ALCL with BIOCELL implants was about six times the risk with textured implants from other manufacturers sold in the U.S. The recall removed unused products from suppliers and doctors' offices2.

The FDA said it does not recommend removing implants from people who have no symptoms, because removal carries its own risks2. Anyone with implants who notices swelling, a lump or pain near an implant should see a doctor.

In October 2021, the FDA restricted the sale and distribution of breast implants to make sure patients receive risk information before surgery, and approved updated labeling3.

Key dates

  1. 2011

    FDA first identifies a possible link between breast implants and ALCL1.

  2. July 24, 2019

    Allergan begins a worldwide recall of BIOCELL textured implants and certain tissue expanders2.

  3. Oct. 27, 2021

    FDA restricts sale of breast implants and approves updated labeling3.

Breast implant illness

The FDA says patients and clinicians use "breast implant illness" for systemic symptoms such as fatigue, memory or concentration problems, joint and muscle pain, hair loss, weight changes, anxiety and depression. These symptoms have been reported with all types of implants, regardless of fill, shape or surface. Some patients report improvement after removal. But the FDA says the cause of the symptoms, and how much they relate to implants, is unclear, and that BII is not a formal medical diagnosis with specific tests or criteria4.

That uncertainty matters for any claim. A BII review looks closely at the implant history, the timing of symptoms, what doctors evaluated and ruled out, and what was found if implants were removed. It doesn't assume that removal will resolve symptoms.

Other breast implant complications

The FDA lists other risks of breast implants, including capsular contracture (scar tissue that tightens around the implant), rupture and deflation, and additional surgeries. It has also reported cases of squamous cell carcinoma and other lymphomas found in the scar capsule around implants5.

BIA-ALCL at a glance

What it is
A non-Hodgkin lymphoma, not breast cancer1.
Where it's found
Usually in fluid or scar tissue around the implant.
Higher risk
Textured-surface implants.
Removal without symptoms
Not recommended by the FDA2.

Breast implant litigation

Federal cases over Allergan BIOCELL textured implants are coordinated in MDL No. 2921 before Judge Brian R. Martinotti in the District of New Jersey. The JPML's Nov. 2, 2026 report lists 1,370 actions pending and 1,586 total6. An MDL coordinates individual cases and is not a class action or a settlement7.

Who may have a breast implant claim

  • A BIA-ALCL diagnosis confirmed by pathology
  • Treatment for BIA-ALCL, including implant and capsule removal, chemotherapy or radiation
  • A history of textured implants or textured tissue expanders
  • Removal or revision surgery with documented findings
  • Systemic symptoms evaluated by doctors, with a clear timeline

Who may be responsible

An investigation may look at the companies that made each implant and expander, based on the product's surface, its labeling, recalls and when it was placed. Surgical care questions are reviewed separately.

Filing deadlines for breast implant lawsuits

Deadlines depend on your state and on when you learned of the diagnosis and its possible cause. Examples:

  • Arizona: generally two years for personal injury and wrongful death8.
  • California: two years for injury to or death of a person caused by another's wrongful act or neglect9.
  • New York: three years for personal injury10, with a separate rule that runs from discovery for injuries caused by the latent effects of exposure to a substance in the body11.
  • Texas: two years for personal injury and wrongful death12, and most product liability claims must be brought within 15 years of the product's sale13.

When the clock starts can depend on when a person knew, or should have known, about the injury and its possible cause. Rules for minors, wrongful death and claims against public hospitals can differ. A device that was part of an earlier settlement can raise its own questions. Ask a medical device attorney to check the rules for your state early, before records are lost.

Tell Us Your Story →

Records that help a breast implant review

Records worth gathering

Implant history

  • Implant cards for every implant and expander
  • Original and replacement operative reports
  • Model, style and lot numbers

Diagnosis

  • Fluid or tissue pathology
  • Oncology records
  • Imaging

Removal

  • Explant operative report
  • Capsule pathology
  • A timeline of symptoms

What happens after you contact CBW Law

How a review works

  1. Tell us what happened

    Share what you remember about the implants, the problem and the treatment that followed. You do not need every record first.

  2. We identify the device

    We work to confirm the maker, model and lot or serial number, and whether any recall or safety notice covers it.

  3. We gather records

    With your permission, we request operative reports, imaging, device data and other records from your providers.

  4. We explain what we see

    We tell you what the records show, what questions remain and what options may be open, including deadlines.

Having implants, or having had a recalled implant, is not by itself a claim. A diagnosis, the implant history and the records come first.

Plain English

Medical, Health & Insurance

Terms you may see in a breast implant case.

Implant terms

Textured implant
An implant with a rough outer surface; linked to higher BIA-ALCL risk1.
Tissue expander
A temporary implant used to stretch tissue before reconstruction.
Capsule
The scar tissue that forms around an implant.

Diagnosis

Seroma
Fluid that collects around the implant.
CD30
A protein that labs test for when diagnosing BIA-ALCL.

Treatment

Explant
Surgery to remove an implant.
Capsulectomy
Surgery to remove the scar capsule around an implant.

Questions

Breast implant lawsuit questions

Short answers to the questions people ask first.

Is BIA-ALCL breast cancer?

No. The FDA describes it as a non-Hodgkin lymphoma, a cancer of the immune system, usually found near the implant.

Does breast implant illness mean I have lymphoma?

No. BII describes systemic symptoms; BIA-ALCL is a specific cancer diagnosed by testing.

Why does implant texture matter?

The FDA has found BIA-ALCL risk is higher with textured-surface implants than with smooth ones.

Should I have my implants removed?

The FDA does not recommend removal for people without symptoms. Talk to your doctor about any swelling, lump or pain.

What if my original implant was replaced?

Every implant and expander matters, including ones that were removed. Bring the full history to a review.

Do I need a breast implant lawyer if I was diagnosed with BIA-ALCL?

A breast implant lawyer can review the diagnosis, the implant history and any recall to explain options and deadlines.

Is there a breast implant class action?

Federal Allergan BIOCELL cases are in multidistrict litigation, MDL No. 2921, which coordinates individual cases.

Will removing implants cure BII symptoms?

Some people report improvement, but the FDA says the cause of these symptoms and their link to implants are unclear.

How long do I have to file a breast implant lawsuit?

It depends on your state and on when you learned of the diagnosis and its possible cause. A breast implant attorney can check.

What does it cost to contact CBW Law?

Telling us your story costs nothing, and contacting us does not create an attorney-client relationship.

Tell Us Your Story

If you were diagnosed with BIA-ALCL or had documented complications after breast implants, a breast implant attorney can review what happened.

Tell us what happened. CBW Law will review your information and explain what we see. Submitting information does not establish an attorney-client relationship or guarantee representation.

Tell Us Your Story Call (800) 476-2416

This page is general information about breast implant illness and BIA-ALCL. It is not legal or medical advice and does not create an attorney-client relationship. Having implants, having had a recalled implant or having symptoms does not, by itself, establish that an implant caused an illness or that anyone is legally responsible. Talk to your doctor before any decision about your implants. Laws and deadlines differ by state, and no outcome can be promised.

Keep reading

Official resources

Government sources for device recalls, safety notices and reporting.

Government

Medical Device Recalls and Early Alerts, FDA

The FDA's list of serious device recalls.

Government

Report a device problem (MedWatch), FDA

Tell the FDA about a problem with a device.

Government

BIA-ALCL questions and answers, FDA

What the FDA says about the lymphoma.

Government

Risks and Complications of Breast Implants, FDA

The full list of known risks.

Apparatus

Sources & Cited Articles

The source material behind each factual, medical and legal statement on this page, numbered to match the markers in the text.

  1. Questions and Answers about Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)U.S. Food and Drug Administration · FDA.gov, content current as of Oct. 23, 2019; verified Nov 12, 2026BIA-ALCL is a non-Hodgkin lymphoma, not breast cancer; where it is found; symptoms; treatment; higher risk with textured surfaces; certain textured tissue expanders.
  2. FDA takes action to protect patients from risk of certain textured breast implants; requests Allergan voluntarily recall certain breast implants and tissue expanders from the marketU.S. Food and Drug Administration · FDA news release, July 24, 2019; verified Nov 12, 2026Worldwide recall of Allergan BIOCELL textured implants and Natrelle 133 tissue expanders; BIOCELL risk about six times other textured implants in the U.S.; FDA does not recommend removal for patients without symptoms.
  3. Labeling for Approved Breast ImplantsU.S. Food and Drug Administration · FDA.gov, content current as of Feb. 6, 2025; verified Nov 12, 2026On Oct. 27, 2021 the FDA restricted sale and distribution of breast implants to ensure patients receive risk information, and approved updated labeling.
  4. Medical Device Reports for Systemic Symptoms in Women with Breast ImplantsU.S. Food and Drug Administration · FDA.gov, content current as of Feb. 6, 2025; verified Nov 12, 2026Symptoms described as breast implant illness; reported with all implant types; cause unclear; not a formal diagnosis with no specific test; MDR limits.
  5. Risks and Complications of Breast ImplantsU.S. Food and Drug Administration · FDA.gov, content current as of Dec. 15, 2023; verified Nov 12, 2026Capsular contracture, rupture, reoperation, BIA-ALCL, reports of squamous cell carcinoma and other lymphomas in the capsule, systemic symptoms.
  6. Pending MDL Dockets by Actions Pending (report date Nov. 2, 2026)United States Judicial Panel on Multidistrict Litigation · JPML statistics report; verified Nov 12, 2026Lists each pending MDL with its court, judge, actions pending and total actions.
  7. About the PanelUnited States Judicial Panel on Multidistrict Litigation · JPML; verified Nov 12, 2026Centralizes federal cases sharing common questions of fact for coordinated pretrial proceedings; cases not resolved are remanded.
  8. A.R.S. § 12-542Arizona State Legislature · Arizona Revised Statutes; verified Nov 12, 2026Two years for injury to the person and for wrongful death.
  9. Code of Civil Procedure § 335.1California Legislature · California Code; verified Nov 12, 2026Two years for injury to or death of an individual caused by the wrongful act or neglect of another.
  10. Civil Practice Law and Rules § 214New York State Senate · Consolidated Laws of New York; verified Nov 12, 2026Three years for personal injury.
  11. Civil Practice Law and Rules § 214-cNew York State Senate · Consolidated Laws of New York; verified Nov 12, 2026Latent effects of exposure to a substance: three years computed from discovery of the injury.
  12. Civil Practice and Remedies Code § 16.003Texas Legislature · Texas Statutes; verified Nov 12, 2026Two years for personal injury and wrongful death.
  13. Civil Practice and Remedies Code § 16.012Texas Legislature · Texas Statutes; verified Nov 12, 2026Products liability actions within 15 years of sale, with an exception for certain latent diseases from exposure.

Accountability

Reviewed by

Craig Weiss, founder and managing attorney of CBW Law Firm

Craig Weiss

Managing Attorney · CBW Law

View full profile →

Attorney advertising. The content of this website may be considered attorney advertising under the rules of certain jurisdictions. The information on this website is for general information purposes only and should not be taken as legal advice for any individual case or situation. Viewing this site does not create an attorney-client relationship. Prior results do not guarantee a similar outcome. Statutes, regulations and case law change, and the law differs from state to state.